Pharma Market Research Conference (PMRC) USA 2019

Pharma Market Research Conference (PMRC) USA is organized by Pharma Market Research Conference (PMRC) and will be held from Feb 06 - 07, 2019 at Newark Liberty International Airport Marriott, Newark, New Jersey, United States of America.

Who Should Attend:
The Pharma Market Research Conference is widely attended by a large variety of professionals from large, medium-sized, and emerging pharmaceutical, biotechnology, medical device, and diagnostics companies.

• Market Research/Marketing Research
• Global Marketing/Marketing
• Brand Management/Product Management
• Strategic Planning/Business Planning
• Business Research
• Qualitative Research/Quantitative Research
• New Products/Product Planning and Analysis
• Business Intelligence/Competitive Intelligence
• Customer Insights
• Knowledge/Information Management
• Industrial Research/Information
• Customer-Scientific-Medical Research/Information
• Emarketing/eBusiness/eDetailing
• Business Development/Marketing and Sales

Conference Description:
The 10th Annual Pharma Market Research Conference is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics. With a sterling reputation of having strong industry support, PMRC offers covers everything you need to know for pharmaceutical market research, presented by internationally renowned speakers from premier companies such as Agile Therapeutics, Agios Pharmaceuticals, Amicus Therapeutics, AstraZeneca, Bayer, Biogen, Bristol-Myers Squibb, Celgene, Eagle Pharmaceuticals, Eli Lilly and Company,  Exicure , Geron Corporation, Insmed, Intarcia Therapeutics, Intercept Pharmaceuticals, Ipsen, Janssen, Jazz Pharmaceuticals, Johnson & Johnson, Karyopharm Therapeutics, Mallinckrodt, Market Strategies International, Merck,  Noden  Pharma, Novartis, Pfizer, Purdue Pharmaceuticals, Rafael Pharmaceuticals, Roche, Sanofi, Shire, Sobi, Sunovion Pharmaceuticals, Taiho Oncology, Takeda, and more! 

The purpose of this conference is to share and generate ideas in the field of pharmaceutical market research. It is the intention of the conference organizers to operate in strict compliance with all state and federal laws, including, but not limited to, antitrust laws. Nothing discussed in this conference is intended to restrain competition. Participants should adhere to the meeting agenda and to voice any concern that the discussion is straying outside these bounds. Participants are encouraged to familiarize themselves with and abide by their own organization’s guidelines.

Conference Objectives:
The Pharma Market Research Conference is the best-in-class conference for pharmaceutical, biotechnology, medical device, and diagnostic market research executives. This conference has been established as the industry leader.

• Unparalleled Networking: Meet hundreds of your peers from the US and around the world in one place at one time. There is no other place to meet all the established and emerging industry leaders in just two days.
• Superior Speakers: Learn and discuss key industry news and challenges with senior level speakers. The depth of knowledge of our speaking faculty can’t be found anywhere else.
• Expansive Coverage: With multiple sessions (presentations, panel discussions, roundtable discussions, and workshops), we cover every topic from top to bottom–from global industry macro issues to strategies to tactical issues in the US, Europe, and Canada. With so many parallel, concurrent sessions to choose from, each participant may tailor their agenda to fit their specific needs. So whether you’re a seasoned professional with 20 years of experience, or a new entrant to this field, your conference experience will be designed just for you.
• Exclusive, High Level Attendance: As the only truly focused Pharma Market Research conference, we boast the most intimate setting of high level executives. We have the highest ratio of industry practitioners (pharma biotech, medical device and diagnostics) of any pharma market research conference, and we keep the setting casual and intimate.
• Network Driven Sponsorships and Exhibition: We limit the exhibition hall to only the premier solution providers. Our limited capacity for exhibition ensures strong networking opportunities and a robust ROI. Every year industry practitioners meet with our vendors to find solutions to their current projects as well as to staff for their projected needs for the following year.

Speakers: Juliana Abbott, Director, Team Leader, Business Analytics & Insights, Pfizer, Praveen Advani, Commercial Insights & Strategy Lead - US Diabetes, Janssen Pharmaceuticals, Lisa Courtade, Executive Director, Global Customer & Brand Insights, Merck, Sandipa Dublish, Senior Director Market Research Inflammation & Immunology, Celgene, Stuart Greenberg, Deputy Director, Global/Oncology Market Research, Bayer, Grace Samoil Reynolds, Market Insights I&I, Celgene, David Rosen, Executive Director, Forecasting, Analytics & Market Research, Purdue Pharmaceuticals, Jeet Uppal, Worldwide Lead - Global Market Research Capabilities, Bristol-Myers Squibb, President & CEO, Agile Therapeutics, Associate Director, Program Management, Agios Pharmaceuticals, Head of Decision Support & Market Analytics, Amicus Therapeutics, Sr. Business Insights Director, AstraZeneca, Deputy Director, Global Market Research, Oncology, Bayer, Associate Director Global Customer & Market Insights, Biogen, Director, R&D Portfolio Optimization and Global Demand Planning, Bristol-Myers Squibb, Vice President - Head of Forecasting, Bristol-Myers Squibb, Director, Forecasting and Analytics, Eagle Pharmaceuticals, Vice President - US Head of Sales, Eagle Pharmaceuticals, Consultant, Market Research - Diabetes, Eli Lilly and Company, VP, Head of Business Development, Exicure, Executive Vice President, Business Development and Portfolio & Alliance Management, Geron Corporation, Associate Director of Customer Insights, Insmed Incorporated, Executive Director, Customer Insights, Analytics & Operations, Intarcia Therapeutics, Vice President, Head of Business Development, Intercept Pharmaceuticals, Director, Commercial Strategy, Ipsen, Commercial Insights & Strategy, Janssen, Senior Manager, Business Intelligence/Sleep Franchise, Jazz Pharmaceuticals, Procurement, Market Research, Johnson & Johnson, Senior Director of Commercial Analytics, Karyopharm Therapeutics, Director, Strategic Business Insights, Forecasting & Analytics, Mallinckrodt, Sr. Product Manager, Pulmonology, Mallinckrodt, Director, Global Customer and Brand Insights, Merck, Director, Global Customer Insights, Merck, Executive Director, Commercial Insights and Salesforce Operations, Noden Pharma, Associate Director, Insights & Analytics, Novartis, Director, Pipeline and BDL Forecasting, Early Commercial Strategy Group, Novartis Oncology, Lung Cancer and Melanoma Lead, Global Business Analysis, Novartis Oncology, Director, Market Analytics - Specialty Care, Pfizer, Director, World Wide Market Analytics, Pfizer, Sr. Manager, Business Analytics and Insights, Xeljanz HCP Lead, Pfizer, President & CEO, Rafael Pharmaceuticals, Marketing Analytics Lead, Roche Diabetes Care, DCV Market Research, Sanofi, Diabetes and CV Market Research, Sanofi, Global Director of Forecasting, Insights and Analytics, Sanofi, Insights and Analytics Lead, Shire, Director, Payer Strategy and Marketing, Sobi, Senior Director, Commercial Analytics, Sunovion Pharmaceuticals, Director, New Product Planning, Taiho Oncology, Associate Director, Global Market Research, Janssen

Additional details will be posted as soon as they are available.